UPDATE 1-Merck KGaA seeks partner for immuno-oncology drug by year-end

* Pharma head Oschmann appointed deputy CEO (Adds details on drug, wraps in management changes)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.